A two minute liquid based sample preparation for rapid SARS-CoV2 real-time PCR screening: A multicentre evaluation

Diagnostic workflows for SARS-CoV-2 have faced significant disruptions due to supply chain issues. Limited availability of reagents and equipment has led to suboptimal testing procedures. Prior research has shown that traditional nucleic acid extraction methods require extensive resources and time. No prior work had resolved the challenge of rapid sample preparation without compromising accuracy. This gap motivated the development of alternative workflows. Researchers have proposed various methods to streamline testing. However, these approaches lacked validation across multiple clinical settings. The need for a reliable, rapid, and scalable diagnostic method remains unmet.

This study aimed to evaluate a novel liquid-based sample preparation method for SARS-CoV-2 detection. The goal was to assess the feasibility of a rapid protocol compared to established diagnostic methods. The focus was on performance in terms of accuracy and reproducibility. The researchers sought to determine if a reduced sample input volume could maintain diagnostic sensitivity. They also aimed to validate the method across multiple clinical centers. Automation compatibility was another key objective. The study targeted a solution that could be deployed in resource-limited settings. The ultimate aim was to support pandemic management through faster diagnostic workflows.

The study compared the QIAprep& Viral RNA UM kit (QIA P&A) to standard diagnostic protocols. Clinical samples from four Dutch hospitals were analyzed using both methods. The QIA P&A protocol involved a two-minute liquid-based preparation step. Results were compared using cycle threshold (C_T) values from real-time PCR. Both manual and automated procedures were tested in parallel. A total of 377 clinical samples were included in the evaluation. The study assessed concordance between the new and standard methods. The performance was evaluated across a range of viral loads and sample types.

The QIA P&A method showed high concordance with standard diagnostic procedures. Of 377 samples, 202 were SARS-CoV-2 positive with C_T values up to 33. Only one sample with a C_T of 31 showed a discrepancy. Prospective testing of 60 additional samples confirmed 100% agreement. The method performed well with an input volume of just 8 μL. Automated testing was successfully implemented in two centers. The protocol maintained diagnostic accuracy across different clinical settings. These findings suggest the QIA P&A kit could serve as a reliable alternative to traditional methods.

The QIA P&A protocol demonstrated strong performance in SARS-CoV-2 detection. The study found that the method could be used with minimal sample input while maintaining accuracy. The researchers propose that this approach could support rapid diagnostic workflows. The results suggest compatibility with both manual and automated testing platforms. The method may help address supply chain limitations in PCR testing. The study supports the use of liquid-based sample preparation in clinical settings. The findings align with the goal of improving diagnostic efficiency during the pandemic. The authors suggest further evaluation in diverse clinical environments.